M3, Inc. (TSE:2413) acquired MinaCare Co., Ltd on June 3, 2024. MinaCare's Chief Executive Officer, Mr. Yamamoto, is to join M3 as Chief Healthcare Officer.
M3, Inc. (TSE:2413) completed the acquisition of MinaCare Co., Ltd on June 3, 2024.
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
M3, INC. 
